Oruka Therapeutics, Inc. Common Stock

$87.00
+1.61 (+1.89%)

Market Capitalization:

$5.25B

Oruka Therapeutics Price Chart

Oruka Therapeutics Price Chart1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM88.6987.9887.2786.5585.8485.1384.42

Oruka Therapeutics Volume Chart

Oruka Therapeutics Volume Chart1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM267.85K229.59K191.32K153.06K114.79K76.53K38.26K

Oruka Therapeutics Market Segments

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+1.62(+1.90%)
Open$85.38
Close$87.00
Low$85.38
Low Change0.00 (0.00%)
High$88.00
High Change+2.62 (+3.07%)
Range$2.62
Volume272.966K
Dollar Volume$23.75M

Regular Trading Hours Yesterday

+5.33(+6.66%)
Open$80.06
Close$85.39
Low$79.00
Low Change-1.06 (-1.32%)
High$88.83
High Change+8.77 (+10.95%)
Range$9.83
Volume3.89M
Dollar Volume$332.18M

Premarket Yesterday

+7.95(+10.60%)
Open$74.99
Close$82.94
Low$74.99
Low Change0.00 (0.00%)
High$85.50
High Change+10.51 (+14.02%)
Range$10.51
Volume32.69K
Dollar Volume$2.71M

Oruka Therapeutics Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Oruka Therapeutics Moving Averages

5 Day Moving Average (SMA5)$73.05
10 Day Moving Average (SMA10)$69.88
20 Day Moving Average (SMA20)$64.14
50 Day Moving Average (SMA50)$65.09
100 Day Moving Average (SMA100)$51.90
200 Day Moving Average (SMA200)$39.00

Oruka Therapeutics Statistics

Average Volume (30 Days)1.28M
P/E Ratio (Current)-43.84
EPS (Current)-$1.65
Dividend Yield0.00%
Free Cash Flow-$91.19M
Cash Ratio2.98
Current Ratio23.76
Quick Ratio23.76
Debt to Equity0.00
Enterprise Value$4.31B
EV to EBITDA-32.36
EV to Sales
Price to Book8.96
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.20%
Return on Equity-0.20%

Oruka Therapeutics Stock Splits

There have been no stock splits for Oruka Therapeutics (ORKA).

Oruka Therapeutics Dividends

There have been no dividends for Oruka Therapeutics (ORKA).